Primary Navigation for the CDC Web Site
CDC en Español
National Program of Cancer Registries (NPCR)
divider
Email Icon Email this page
Printer Friendly Icon Printer-friendly version
divider
 View by Topic
bullet U.S. Cancer Statistics
bullet Data
bullet Informatics
bullet Software and Tools
bullet Training
bullet NPCR Education and Training Series (NETS)
bullet Brain Tumor Registry Reporting Training Materials
bullet Educational Materials for Cancer Registrars
bullet How to Collect High-Quality Cancer Surveillance Data
bullet Cancer Surveillance System Rationale and Approach
bullet Registry Operations Resources
bullet Publications
bullet About the Program
bullet Contacts
bullet Partners

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

Brain Tumor Registry Reporting Training Materials
Other Materials

Surveillance of Primary Intracranial and Central Nervous System Tumors: Recommendations from the Brain Tumor Working Group
References

  • Overview
  • Slide Presentation
  • Exercises
  • Other Materials
  • Collection and Coding Clarifications
  •  Surveillance of Primary
     Intracranial and Central
     Nervous System Tumors
    bullet Preface
    bullet Executive Summary
    bullet Introduction
    bullet Background
    bullet Methods
    bullet Results
    bullet Discussion
    bullet Recommendations
    bullet References
    bullet Tables
    bullet Appendix A
    bullet Appendix B
    bullet Appendix C
    bullet Appendix D
    1. Davis F, Preston-Martin S. Epidemiology of brain tumors. In Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's pathology of tumors of the nervous system, ed 6. London, Arnold Publishing, 1996:5–45.
       
    2. World Health Organization (WHO) (1976) International classification of diseases for oncology, ed 1. Geneva: World Health Organization.
       
    3. World Health Organization (WHO) (1990) International classification of diseases for oncology, ed 2. Geneva: World Health Organization.
       
    4. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255–268.
       
    5. Thapar K, Laws ER. Tumors of the central nervous system. In Murphy GP, Lawrence W Jr, Lenhard RE Jr, eds. Textbook of clinical oncology, ed 2. Atlanta, American Cancer Society 1995;378–410.
       
    6. Walker AE, Robins M, Weinfield FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurol 1985;35:219–226.
       
    7. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK (eds). SEER Cancer Statistics Review, 1973–1995, National Cancer Institute. Bethesda, MD, 1998.
       
    8. Cancer Facts & Figures – 1998. American Cancer Society, Atlanta, Georgia, 1998.
       
    9. Davis FG, Bruner JM, Surawicz TS. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiol 1997;16:308–316.
       
    10. CBTRUS (1996) First annual report 1995. Central Brain Tumor Registry of the United States. Chicago, Illinois.
       
    11. Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol Clinics 1996;14:273–290.
       
    12. Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1991; 83:1621–1624.
       
    13. Mao Y, Desmeules M. Semenciw RM, Hill G, Gaudette L, Wigle DT. Increasing brain cancer rates in Canada. Can Med Assoc J 1991;145:1583–1591.
       
    14. Frelick R. Huang P, Topham A. Brain and central nervous system tumors: Delaware 1980 to 1989. Del Med J 1992;64:571–573.
       
    15. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991;19:421–431.
       
    16. Helseth A. Increasing incidence of primary central nervous system tumors in the elderly: Real increase or improved detection? J Natl Cancer Inst 1993;85:1871–1872.
       
    17. Modan B, Wagener D, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: A combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1992;135:1349–1357.
       
    18. Polednak AP. Time trends in the incidence of brain and central nervous system cancers in Connecticut, J Natl Cancer Inst 1991;83:1679–1681.
       
    19. Boyle P, Maissonneuve P, Saracci R, Muir CS. Is the increase in incidence of primary malignant brain tumors real? J Natl Cancer Inst 1990;20:1594–1596.
       
    20. Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and spinal meninges in Los Angeles County. Neuroepidemiol 1989;8:283–295.
       
    21. Helseth A, Mork SJ. Neoplasms of the central nervous system in Norway. Epidemiological characteristics of intracranial gliomas according to histology. APMIS 97 1989;547–555.
       
    22. Gurney JG, Davis S, Severson RK, Fang J-Y, Ross JA, Robison LL. Trends in cancer incidence among children in the United States. Cancer 1996;78:532–541.
       
    23. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. Infant cancer in the U.S.: histology-specific incidence trends, 1973–1992. J Pediatr Hem Onc 1997;19:428–432.
       
    24. Nishio S, Takeshita I, Morioka T, Fukui M. Primary intracranial squamous cell carcinomas: report of two cases. Neurosurgery 1995;37:329–332.
       
    25. Freilich RJ, Thompson SJ, Walker RW, Rosenblum MK. Adenocarcinomatous transformation of intracranial germ cell tumors. Am J Surg Pathol 1995;19:537–544.
       
    26. Yuan S, Miller DW, Barnett GH, Hahn JF, Williams BR. Identification and characterization of human beta 2-chimaerin: association with malignant transformation in astrocytoma. Cancer Research 1995; 55:3456–3461.
       
    27. Preston-Martin S, Mack WJ. Neoplasms of the nervous system. In Schoenfeld D, Fraumeni JF Jr., eds. Cancer epidemiology and prevention, ed 2. New York, Oxford University Press, 1996:1231–1281.
       
    28. Riggs JE. Rising primary malignant brain tumor mortality in the elderly. A manifestation of differential survival. Arch of Neurol 1995;52:571–575.
       
    29. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg 1998;88:1–10.
       
    30. Surawicz TS, Davis F, Freels S, Laws ER, Menck HR. Brain tumor survival: results from the National Cancer Data Base. (Accepted for publication in J Neuro-Oncol)
       
    31. Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991;8:253–267.
       
    32. Preston-Martin S, Monroe K, Lee P, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal meningiomas in women in Los Angeles County: Investigation of an etiologic hypothesis. Cancer Epidemiol Biomarkers Prev 1995;4:333–339.
       
    33. Davis JR, Brownson RC, Garcia R, Bentz BJ, Turner A. Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol 1993:24:87–92.
       
    34. Commission on Cancer. General principles and coding. In Standards of the Commission on Cancer, vol. II: Registry Operations and Data Standards. American College of Surgeons. Chicago, Illinois. 1996.
       
    35. Central Brain Tumor Registry of the United States (CBTRUS). 1997 State Survey of Benign Brain Tumor Collection. Chicago, Illinois. 1997.
       
    36. Davis FG, Malinski N, Haenszel W, Chang J, Flannery J, Gershman S, Dibble R, Bigner DD. Primary brain tumor incidence rates in the four United States regions, 1985–1989: A pilot study. Neuroepidemiol 1996;15:103–112.
       
    37. Schoenberg BS, Christine BW, Whisnant JP. The descriptive epidemiology of primary
      intracranial neoplasms: the Connecticut experience. Am J Epidemiol 1976;104:499–510.
    Page last reviewed: September 26, 2006
    Page last updated: September 26, 2006
    Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
      Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
    Safer, Healthier People

    Centers for Disease Control and Prevention
    1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
    800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
    USA.govDHHS Department of Health
    and Human Services